Pekin Hardy Strauss, Inc. Pfizer Inc Transaction History

Pekin Hardy Strauss, Inc.

$785 Million
Q1 2025

A detailed history of Pekin Hardy Strauss, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 10,179 shares of PFE stock, worth $238,799. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,179

Previous 21,895 53.51%

Holding current value

$238,799

Previous $580,000 55.69%

% of portfolio

0.03%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$25.01 - $27.13 $293,017 - $317,855	-11,716 Reduced 53.51%	10,179 $257,000
Q4 2024 Feb 03, 2025	SELL	$24.8 - $30.19 $148,800 - $181,140	-6,000 Reduced 21.51%	21,895 $580,000
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $22,160 - $25,112	800 Added 2.95%	27,895 $807,000
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $52,793 - $61,864	2,090 Added 8.36%	27,095 $758,000
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $30,058 - $34,516	-1,161 Reduced 4.44%	25,005 $693,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $978,777 - $1.27 Million	-37,458 Reduced 58.87%	26,166 $753,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $114,561 - $133,910	-3,570 Reduced 5.31%	63,624 $2.11 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $95,103 - $110,033	-2,633 Reduced 3.77%	67,194 $2.46 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $101,192 - $131,738	-2,569 Reduced 3.55%	69,827 $2.85 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $81,746 - $106,711	-1,958 Reduced 2.63%	72,396 $3.71 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $1,706 - $2,083	39 Added 0.05%	74,354 $3.25 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $69,795 - $82,755	1,500 Added 2.06%	74,315 $3.9 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $32,025 - $39,683	-700 Reduced 0.95%	72,815 $3.77 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $41,320 - $61,250	1,000 Added 1.38%	73,515 $4.34 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $42,900 - $55,109	1,093 Added 1.53%	72,515 $3.12 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $58,353 - $66,105	1,625 Added 2.33%	71,422 $2.8 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $126,759 - $142,959	3,785 Added 5.73%	69,797 $2.53 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $49,870 - $63,414	1,490 Added 2.31%	66,012 $2.43 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $139,700 - $163,900	4,400 Added 7.32%	64,522 $2.37 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $14,668 - $17,794	-487 Reduced 0.8%	60,122 $1.97 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $52,438 - $74,922	-1,940 Reduced 3.1%	60,609 $1.98 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $5,761 - $6,538	-175 Reduced 0.28%	62,549 $2.45 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $266,093 - $345,044	-8,190 Reduced 11.55%	62,724 $2.25 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $10,354 - $11,625	-280 Reduced 0.39%	70,914 $3.07 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $7,500 - $8,240	-200 Reduced 0.28%	71,194 $3.02 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $526,692 - $600,487	13,691 Added 23.73%	71,394 $3.12 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $90,483 - $109,751	-2,625 Reduced 4.35%	57,703 $2.54 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $214,864 - $229,067	-6,515 Reduced 9.75%	60,328 $2.19 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $11,966 - $13,882	-375 Reduced 0.56%	66,843 $0
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $163,672 - $173,662	-4,921 Reduced 6.82%	67,218 $0
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $2.24 Million - $2.46 Million	72,139	72,139 $2.58 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.

Account

Pekin Hardy Strauss, Inc. Pfizer Inc Transaction History